Compile Data Set for Download or QSAR
Report error Found 93 Enz. Inhib. hit(s) with all data for entry = 11092
TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727277(US20250091992, Compound 6)
Affinity DataIC50: 2nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727274(US20250091992, Compound 3)
Affinity DataIC50: 5nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727965(US20250091992, Compound 13)
Affinity DataIC50: 20nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727317(US20250091992, Compound 7)
Affinity DataIC50: 20nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727968(US20250091992, Compound 24)
Affinity DataIC50: 20nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727214(US20250091992, Compound 2)
Affinity DataIC50: 30nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727967(US20250091992, Compound 21)
Affinity DataIC50: 30nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetIsoform 2 of 3',5'-cyclic-AMP phosphodiesterase 4D(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727191(US20250091992, Compound 1)
Affinity DataIC50: 100nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727971(US20250091992, Compound 31)
Affinity DataIC50: 100nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727191(US20250091992, Compound 1)
Affinity DataIC50: 100nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetIsoform 2 of 3',5'-cyclic-AMP phosphodiesterase 4D(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727373(US20250091992, Compound 11)
Affinity DataIC50: 100nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727275(US20250091992, Compound 4)
Affinity DataIC50: 100nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727350(US20250091992, Compound 9)
Affinity DataIC50: 100nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetIsoform 2 of 3',5'-cyclic-AMP phosphodiesterase 4D(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727277(US20250091992, Compound 6)
Affinity DataIC50: 200nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727974(US20250091992, Compound 35)
Affinity DataIC50: 200nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetIsoform 2 of 3',5'-cyclic-AMP phosphodiesterase 4D(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727214(US20250091992, Compound 2)
Affinity DataIC50: 200nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727969(US20250091992, Compound 25)
Affinity DataIC50: 300nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727351(US20250091992, Compound 10)
Affinity DataIC50: 300nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727330(US20250091992, Compound 8)
Affinity DataIC50: 400nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727970(US20250091992, Compound 27)
Affinity DataIC50: 400nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727975(US20250091992, Compound 36)
Affinity DataIC50: 400nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727977(US20250091992, Compound 38)
Affinity DataIC50: 400nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetIsoform 2 of 3',5'-cyclic-AMP phosphodiesterase 4D(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727965(US20250091992, Compound 13)
Affinity DataIC50: 500nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetIsoform 2 of 3',5'-cyclic-AMP phosphodiesterase 4D(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727317(US20250091992, Compound 7)
Affinity DataIC50: 500nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetIsoform 2 of 3',5'-cyclic-AMP phosphodiesterase 4D(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727970(US20250091992, Compound 27)
Affinity DataIC50: 600nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727373(US20250091992, Compound 11)
Affinity DataIC50: 600nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727277(US20250091992, Compound 6)
Affinity DataIC50: 700nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727976(US20250091992, Compound 37)
Affinity DataIC50: 800nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727373(US20250091992, Compound 11)
Affinity DataIC50: 800nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727973(US20250091992, Compound 34)
Affinity DataIC50: 900nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727214(US20250091992, Compound 2)
Affinity DataIC50: 900nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727965(US20250091992, Compound 13)
Affinity DataIC50: 1.00E+3nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727191(US20250091992, Compound 1)
Affinity DataIC50: 1.00E+3nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetIsoform 2 of 3',5'-cyclic-AMP phosphodiesterase 4D(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727967(US20250091992, Compound 21)
Affinity DataIC50: 1.00E+3nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727970(US20250091992, Compound 27)
Affinity DataIC50: 1.20E+3nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetIsoform 2 of 3',5'-cyclic-AMP phosphodiesterase 4D(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727350(US20250091992, Compound 9)
Affinity DataIC50: 1.20E+3nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727317(US20250091992, Compound 7)
Affinity DataIC50: 1.30E+3nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetIsoform 2 of 3',5'-cyclic-AMP phosphodiesterase 4D(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727274(US20250091992, Compound 3)
Affinity DataIC50: 1.30E+3nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetIsoform 2 of 3',5'-cyclic-AMP phosphodiesterase 4D(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727968(US20250091992, Compound 24)
Affinity DataIC50: 1.40E+3nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727967(US20250091992, Compound 21)
Affinity DataIC50: 1.70E+3nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727972(US20250091992, Compound 33)
Affinity DataIC50: 2.10E+3nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727968(US20250091992, Compound 24)
Affinity DataIC50: 2.30E+3nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727964(US20250091992, Compound 12)
Affinity DataIC50: 2.40E+3nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727981(US20250091992, Compound 42)
Affinity DataIC50: 3.00E+3nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetIsoform 2 of 3',5'-cyclic-AMP phosphodiesterase 4D(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727981(US20250091992, Compound 42)
Affinity DataIC50: 3.00E+3nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetIsoform 2 of 3',5'-cyclic-AMP phosphodiesterase 4D(Homo sapiens (Human))
Kanna Health

US Patent
LigandPNGBDBM727980(US20250091992, Compound 41)
Affinity DataIC50: 3.00E+3nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727981(US20250091992, Compound 42)
Affinity DataIC50: 3.00E+3nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Kanna Health

US Patent
LigandPNGBDBM727980(US20250091992, Compound 41)
Affinity DataIC50: 3.00E+3nMAssay Description:SERT assay (Compounds of Formula I): Test compounds (conc range), reference compound or vehicle control were incubated for 180 min at room temperatu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727980(US20250091992, Compound 41)
Affinity DataIC50: 3.00E+3nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B1(Human)
Kanna Health

US Patent
LigandPNGBDBM727979(US20250091992, Compound 40)
Affinity DataIC50: 3.00E+3nMAssay Description:Test compounds (conc range), reference compound or vehicle control were added to assay buffer containing (in mM); Tris/HCl, pH 7.4 (40), MgCl2 (8) an...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/12/2023
Entry Details
US Patent

Displayed 1 to 50 (of 93 total ) | Next | Last >>
Jump to: